Ivana Filipović

Ivana Filipović

Auto-generated profile, based on publicly available information

Ivana Filipović


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2025 in Preventive Paediatrics
Verified
Journal Article
Closed access
Marco CaminatiMarco Caminati
Marco Caminati
IFIvana Filipović
Ivana Filipović
ZŽZorica Živković
Zorica Živković
Atopic dermatitis (AD) is the most common chronic inflammatory skin disorder affecting up to 20% of children. AD is usually the first step of the atopic march, with a sequential progression to respiratory allergic diseases (asthma and allergic rhinitis). The aim of this prospective real life study was to follow up the efficacy of mixture of 3x109 CFU (colony forming unites) of 3 probiotic strains Lactobacillus Casei BL 2401, Lactobacillus Salivarius BL 2201, Bifidobacterium Breve BL 3406 in combination with 7mg Zinc in Hypro-ri form for better resorption and 1200 IJ Vitamin D3 (Imunolak Kids D3 Zn) in the group of children with atopic dermatitis. Tretament period was3 months. Children with mild to moderate AD who have received Imunolak Kids D3 Zn were followed up for the next 6 months after cessation of the probiotic supplementation for AD and respiratory tract diseases (including both upper and lower respiratory tract infection and exacerbation of asthma and/or allergic rhinitis in children with those comorbidities). Our observation showed that 6 months after cessation of the treatment AD was under control, while although during the study we noticed less respiratory tract diseases, 3 months of probiotic usage didn’t have prolonged effects.

18 April 2026 in Preventive Paediatrics
Verified
Journal Article
Closed access
IFIvana Filipović
Ivana Filipović
BIBojana Ivić
Bojana Ivić
Marco CaminatiMarco Caminati
Marco Caminati
SMSlađana Mihajlović
Slađana Mihajlović
ZŽZorica Živković
Zorica Živković
Introduction: Since the 1970s, AD incidence has increased 2- to 3-fold in industrialized nations, impacting approximately 15% to 20% of children, 5% to 20% of adolescents. Materials and methods: This was 6 months (January to June 2024) retrospective study collecting data through a web-based questionnaire designed to measure knowledge and attitude of Serbian physicians towards AD diagnosis, treatment and prevention strategies. The participants were healthcare professionals, specialists who are treating patients with AD. Surveys can reveal gaps in knowledge, concerns about safety or effectiveness, and the need for further training or support. This insight can help improve clinical guidelines, promote evidence-based practices, and ensure patients receive comprehensive and up-to-date care. Results: Patients with Atopic Dermatitis in Serbia were mostly treated by physicians specialized in pediatrics and dermatology (210 dermatologist and 218 pediatricians were included). Virtually all participants agreed that discovering and avoiding triggering factors are crucial to keep AD under control. Among our participants diagnosing and staging of AD are mostly based on clinical criteria including assessment of itching intensity and sleep disturbance using visual analogue scales and overall quality of life. Discussion: Results of our survey has the potential to identify current knowledge gaps and attitudes of physicians who are treating patients with atopic dermatitis. Physicians who experience less difficulties while treating AD have more positive practice attitudes and treatment satisfaction rates. Conclusion: Continuous medical education, open-mindedness to evolving evidence, and a genuine commitment to understanding the patient’s lived experience are essential for elevating care quality in this challenging and burdensome condition.

18 April 2026 in Preventive Paediatrics
Verified
Journal Article
Closed access
BIBojana Ivić
Bojana Ivić
IFIvana Filipović
Ivana Filipović
SMSladjana Mihajlovic
Sladjana Mihajlovic
Vaccines are the most effective way to prevent infectious diseases. Immunization is a key compo-nent of primary healthcare. Maternal immunization before and/or during the pregnancy proves to significantly reduce maternal and infant morbidity and mortality associated with the diseases caused by pathogens that are relevant to the perinatal period and early life, and for which there are currently no other effective alternative preventive measures. Women can be vaccinated before or during the pregnancy to protect themselves and pass immunity directly to their babies.The mother's immune system in pregnancy plays a key role in the development of child’s immunity. Therefore it is important to explore this area that presents a challenge for deci-sion-making regarding how, when, and why vaccinate women in a reproductive period.